Literature DB >> 7585549

Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA).

W G Jiang1, S Hiscox, M B Hallett, D F Horrobin, R E Mansel, M C Puntis.   

Abstract

E-cadherin is a cell to cell adhesion molecule which acts as a suppressor of metastasis. This study examined the effect of gamma-linolenic acid (GLA), a n-6 polyunsaturated fatty acid, on the expression of E-cadherin in human cancer cells. Western blotting studies demonstrated that treatment of cells with GLA for 24 h increased the expression of E-cadherin in lung, colon, breast, melanoma, and liver cancer cells, but not in endothelial cells and fibroblasts. The results were confirmed by immunocytochemistry. In contrast, two other n-6 fatty acids, linoleic acid and arachidonic acid, failed to induce these changes. The increased expression of E-cadherin was correlated with reduced in vitro invasion and increased aggregation, indicating that the increased E-cadherin expression induced by GLA was biologically active. These data add GLA to the short list of E-cadherin up-regulatory factors. The up-regulation of E-cadherin expression in human cancer cells may contribute to the anticancer properties of GLA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585549

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids.

Authors:  W G Jiang; S K Singhrao; S Hiscox; M B Hallett; R P Bryce; D F Horrobin; M C Puntis; R E Mansel
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+CD18+ cells and CD8+CD103+ cells by multi-epitope imaging.

Authors:  K Ademmer; M Ebert; F Müller-Ostermeyer; H Friess; M W Büchler; W Schubert; P Malfertheiner
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo.

Authors:  Siobhan L Webb; Andrew J Sanders; Malcolm D Mason; Wen G Jiang
Journal:  Mol Cell Biochem       Date:  2012-12-13       Impact factor: 3.396

4.  Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions.

Authors:  Ephraim P Lansky; Wenguo Jiang; Huanbiao Mo; Lou Bravo; Paul Froom; Weiping Yu; Neil M Harris; Ishak Neeman; Moray J Campbell
Journal:  Invest New Drugs       Date:  2005-01       Impact factor: 3.850

5.  Modifications in mitochondrial metabolism and ultrastructure and their relationship to tumour growth inhibition by gamma-linolenic acid.

Authors:  A Colquhoun; R I Schumacher
Journal:  Mol Cell Biochem       Date:  2001-02       Impact factor: 3.396

Review 6.  Are the olive oil and other dietary lipids related to cancer? Experimental evidence.

Authors:  E Escrich; M Solanas; R Moral; I Costa; L Grau
Journal:  Clin Transl Oncol       Date:  2006-12       Impact factor: 3.405

7.  Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel.

Authors:  Ephraim Philip Lansky; Gregory Harrison; Paul Froom; Wen G Jiang
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

8.  Epidermal growth factor receptor targeting alters gene expression and restores the adhesion function of cancerous cells as measured by single cell force spectroscopy.

Authors:  Shohreh Azadi; Mohammad Tafazzoli-Shadpour; Ramin Omidvar; Lida Moradi; Mahdi Habibi-Anbouhi
Journal:  Mol Cell Biochem       Date:  2016-10-01       Impact factor: 3.396

9.  Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer.

Authors:  Ping-Hui Sun; Lin Ye; Malcolm D Mason; Wen G Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-04       Impact factor: 4.553

10.  Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis.

Authors:  Ping-Hui Sun; Lin Ye; Malcolm D Mason; Wen G Jiang
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.